Furthermore, a subset of CTCs and tumor-initiating cells may exhibit dynamic changes in epithelial–mesenchymal transition phenotype (Yu et al., 2013), which can upregulate CD81 expression in mesenchymal breast cancer (Uretmen Kagiali et al., 2019). Here, CD81 is linked to breast carcinoma.